The European Week against Cancer is the time when the EU joins forces in the fight against cancer and we renew our commitment to improve the lives of those touched by this disease. Since 2020, Europe’s Beating Cancer Plan is …
Every day in Europe, new cancer cases are diagnosed. Every day in Europe, patients, their families and friends experience the tidal wave of emotions that a cancer diagnosis brings with it. Uncertainty about the future, feelings of shock, sadness, anger, …
Dr David Heber is the chairman of the Herbalife Nutrition Institute (HNI), which promotes excellence in nutrition education for the public and scientific community and sponsors scientific symposia. The HNI editorial board is made up of key scientific opinion leaders …
Important advancements in diagnosing and treating breast cancer in Europe have been made in the last years. However, there are still many challenges to overcome, writes Lydia Makaroff.
You are what you eat, the saying goes, but what about what we drink? Dietary regulations across Europe need to be stricter if digestive disease rates are to fall, writes Thierry Ponchon.
For glyphosate, the active ingredient in the world’s most widely used weed killer, 6 November will be a date with destiny, writes Pieter Cleppe.
Recently, headlines in Germany and Austria might have made you shiver with fear: “The. EU. Wants. To. Ban. Crispy. Chips”. No less! The same EU which dictates the shape of our bananas and cucumbers is now meddling with our chips. Or is it, asks Monique Goyens.
Putting more than 10 years of paralysis behind it, the European Commission finally launched a revision of the directive on the prevention of occupational cancers in May 2016. Lawmakers can now address reprotoxic substances in the workplace, writes Laurent Vogel.
European red tape should not be an obstacle to effective healthcare. For patients with diseases like sarcoma, waiting means suffering and often avoidable death, writes Marlene Mizzi.
Ever since he took office, Agriculture Commissioner Phil Hogan has promoted the interests of the livestock sector while ignoring health warnings and environmental concerns over meat consumption, writes Olga Kikou.
The austerity policies pursued in several European countries in the wake of the EU fiscal crisis are pushing the public health sector to the brink – and forcing more and more services into private hands, writes Jan Willem Goudriaan on World Health Day (7 April).
Revisiting European policies and legislation to meet the increasing prevalence of skin cancer in outdoor workers should become part of the European agenda, write Swen Malte John and Nikos Manaras.
For many rare cancers patients, it can be difficult to have access to appropriate therapies and clinical expertise, due to the fact that there has been a limited number of clinical studies to find new drugs and treatments, writes Mihaela Militaru.
Given lung cancer’s relative prevalence within Europe when compared to other parts of the world, European Week Against Cancer presents a timely opportunity to discuss what is being done in the fight to reduce its prevalence, writes Jean-Paul Sculier.
It’s important that the fight against cancer takes place every day, and across all policies, writes Catherine Castledine on World Cancer Day, writes Catherine Castledine.
We can do more to prevent people from getting cancer, for example by increasing efforts to reduce the amount of pollutants in the air, says Christian Friis Bach.
?The European Commission must lead the charge in ensuring that lung cancer, an overlooked but deadly killer, is finally given the recognition it needs in order to effectively combat it, writes Mogens Ekelund.
The strength of national hepatitis plans is the bundling of otherwise uncoordinated EU efforts. Many countries are effective only in some aspects of their response to hepatitis, argues Andrey Kovatchev.
Viral hepatitis belongs to the group of the top 10 infectious disease killers in Europe with 125,000 patients who die each year. Despite its considerable impact, it receives too little attention by health policymakers although small efforts could already yield major improvements, says MEP Marina Yannakoudakis.
The EU's risk assessment system for chemicals has derailed and should be reformed urgently in favour of a science-based system that takes full account of the work undertaken by the scientific community, argues Hans Muilerman.
There are many improvements to be made before REACH can fulfil its public health promise to fight diseases such as cancer, obesity, diabetes, impaired fertility and behavioural disorders, writes Paul Whaley from the Cancer Prevention and Education Society.
European cancer patients continue to suffer from a lack of access to quality information and are often lured by untrustworthy sources such as counterfeit online pharmacies. The EU must urgently establish a coherent and comprehensive strategy to allow patients to make informed choices, writes Jan Geissler, director of the European Cancer Patient Coalition (ECPC), in an April blog post.
